Article Types
LymphoSign Journal accepts the following manuscript types.
Editorials and Commentaries
Editorials must include a Title Page and References (if needed). Editorials and commentaries may be up to 10 pages long (excluding references).
Reviews
Reviews must include a Title Page, Abstract, main body of text, and References. Review articles may be up to 30 pages long (excluding title page, abstract, figures, tables, and references) and may include up to 15 figures and 10 tables.
Original Articles
Original articles must include a Title Page, Structured Abstract, Statement of Novelty, Introduction, Methods, Results, Discussion, and References. Original articles may be up to 20 pages (excluding title page, abstract, figures, tables, and references) and may include up to 10 figures and up to 5 tables.
Novel Mutations
Novel mutations include mutation analysis and the pathophysiological impact of novel phenotypes of known genetic disorders. These manuscripts must include a Title Page, Abstract, Statement of Novelty, Introduction, Functional and Clinical Presentation, and References. Novel mutation manuscripts may be up to 10 pages long (excluding title page, abstract, figures, tables, and references) and may include up to 5 figures and up to 3 tables.
Issue Images
Exceptional images may be submitted. The images may cover a wide range of subjects from immunodeficiency-related basic science to clinical imaging (CT, MRI, etc.). Manuscripts accompanying exceptional images must include an Introduction, Methods, Extended Figure Legends, and Discussion. Where possible, all findings must be clearly demonstrated on the images using arrows.
Protocols, Guidelines, and Classifications
Protocols describe new products or modalities of treatment (e.g., IgG replacement, HSCT, gene therapy, or others), practice guidelines, or algorithms. Protocols must include an Abstract. They may be up to 20 pages long (excluding title page, abstract, figures, tables, and references) and may include up to 5 figures and up to 10 tables. Introduction, Methods, and Discussion may be added where appropriate.
Style Guide for Manuscripts
Title Page
Article titles should
- contain important descriptive phrases that relate to the topic
- be clear and concise
- include specific synonyms, conditions, interventions, mechanisms, or functions of the article’s central focus
- contain terms that are specific, rather than general, and include terms that clarify
The title must be followed by:
- the list of authors, including their full names and institutional affiliations
- the name, address, telephone number, fax number, and email address of the corresponding senior author
- a declaration of all sources of funding for the research reported in the manuscripts
Abstract
Abstracts should be structured as follows: Background, Methods, Results, Conclusion
Statement of Novelty
A Statement of Novelty is required for original articles and novel mutations. It should be 1–3 sentences that explicitly state the novel aspects of the work.
Text
The manuscript must be written in clear and concise English, using proper grammar. Authors whose primary language is not English should consult a colleague fluent in English or utilize the services of a professional editor. Revision of manuscripts solely for language-related reasons may result in unnecessary delays in the publication process. Each section of the manuscript should begin on a new page. Up to date nomenclature should be used for descriptions of genes and proteins.
Methods
Experiments Involving Animals
Authors who describe experiments on animals are required to give assurance in the Methods section that appropriate standards (institutional or national) for animal care were upheld.
Patient consent
Authors whose articles contain any information concerning individual patients must obtain and archive written consent from the patient(s) to publish this information in LymphoSign Journal. Authors are also required to provide assurance in the Methods section that appropriate standards for human experimentation have been followed, that the experiment has been reviewed and approved by their institution’s ethics committee, and that informed consent was given prior to participating in the study.
References
In the text, references must be cited by author and date, e.g., Smith (2007) or (Smith 2007), depending on the sentence structure. A complete alphabetical list of the references cited must be included at the end of the manuscript. References to other publications must be carefully checked for completeness, accuracy, and consistency (e.g., page ranges, volume numbers, and dates).
The following bibliographic citations illustrate the punctuation, style, and abbreviations for references.
Journal article with DOI
Bezbradica, J.S., Rosenstein, R.K., Richard A DeMarco, Brodsky, I., and Medzhitov, R. 2014. A role for the ITAM signaling module in specifying cytokine-receptor functions. Nat. Immunol. 15(4): 333–342. doi:10.1038/ni.2845.
Book
Abbas, A.K., and Lichtman, A.H. 2009. Basic immunology: functions and disorders of the immune system. 3rd edition. Saunders Elsevier, Philadelphia.
Part of book
June, C.H., and Grupp, S.A. 2011. Dendritic cell subsets as vectors and targets for improved cancer therapy. In Cancer immunology and immunotherapy. Edited by G. Dranoff. Springer-Verlag, New York. pp.173–192.
Paper in conference proceedings
Cavaillon, J.-M., and Haeffner-Cavaillon, N. 1987. Characterization of the induction of human interleukin-1 by endotoxins. In Proceedings of a NATO Advanced Research Workshop on Lipid Mediators in Immunology of Burn and Sepsis, Helsingor, Denmark, 20–25 July 1986. Edited by M. Paubert-Braquet. Plenum Press, New York. pp. 395-407.
Web site
Quinion, M.B. 1998. Citing online sources: advice on online citation formats [online]. Available from http://worldwidewords.org/articles/citation.htm [accessed 20 October 2005].
Submissions
All manuscripts must be submitted using the ScholarOne Online Submission and Peer Review system: http://mc06.manuscriptcentral.com/lpsn.
All correspondence regarding manuscript submissions is done via e-mail with the corresponding authors.
Text should be provided in a word-processing format (any form of Microsoft Word). Tables and figures may be included in the manuscript file, but must also be uploaded separately. It is up to the submitting author to upload images of high resolution.
Cover Letter
A cover letter must accompany each submission. The cover letter must include the type of article being submitted, a short description of the research, and the reasons why the manuscript should be considered for publication in LymphoSign Journal.
Preferred Reviewers
During the submission process, authors can provide the names, affiliations, and email addresses of up to 5 preferred reviewers who are qualified to examine and review the manuscript. Authors also have the option of listing any non-preferred reviewers.
Required Documents
Transfer of Copyright
All authors are required to submit a completed and signed copyright transfer or license to publish form licensing rights to LymphoSign Journal LP. The Copyright Transfer or Licence to Publish (Manuscript) form is available from www.lymphosign.com/authors/copyright.
Conflict of Interest Disclosure
All authors must acknowledge funding sources that support the work and must disclose other interests that could influence how the work is perceived and understood. All authors must sign and submit the International Committee of Medical Journal Editors (IJCME) Form for Disclosure of Potential Conflict of Interests available from http://www.icmje.org/conflicts-of-interest/.
